Boca Raton, FL, Jan. 27, 2026 (GLOBE NEWSWIRE) -- INmune Bio, Inc. (NASDAQ: INMB), a clinical-stage inflammation and immunology company, presents the following letter to investors from David Moss, CEO ...
Researchers at the new Center for Brain Health at UT Health San Antonio are studying midlife testing for early-onset dementia with blood-based biomarkers to see if they can detect disease activity up ...
The pharmaceutical sector continues to evolve at an unprecedented pace. In this dynamic environment, where hundreds of ...
DelveInsight provides structured pharma conference coverage solutions designed to help industry leaders to track and interpret critical developments emerging from major healthcare conferences.
I caught up with clinical physical therapist Sailboat Lewis to learn how to lower the risk of skiing and snowboarding injuries and make winter sports safer. The post Stay on the slopes, not in the ER: ...
Geron’s CEO outlines Rytelo as a 2026 growth story with $220M–$240M revenue guidance and IMpactMF interim catalyst. See more ...
And on the Beverly Hills Patch calendar - [LIVE THEATRE] How To Die In Japan: Your Normal Is Not My Normal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results